Industry & Policy News

[Oklahoma Medical Research Foundation] The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $5.8 million to work toward easier diagnosis and better treatment options for Sjögren’s disease, an autoimmune condition.

[Aegle Therapeutics Corp (PR Newswire)] Aegle Therapeutics Corp. announced positive 12-week data for the first patient enrolled in a Phase I/IIa clinical trial of AGLE-102™ for the treatment of severe second-degree burns.

[ISS National Laboratory] More than two dozen investigations sponsored by the International Space Station (ISS) National Laboratory, many of which focus on the life sciences, will fly on Axiom Space’s third private astronaut mission to the orbiting laboratory.

[Prevent Cancer Foundation] “From training the country’s first breast radiologists in Zambia and testing AI-supported breast cancer diagnosis in Nigeria to implementing novel approaches for addressing cervical cancer in Cameroon and Mexico, the Prevent Cancer Foundation is proud to support the 2024 Global Innovation Grants as we dare to imagine a world where cancer is preventable, detectable and beatable for all,” said CEO Jody Hoyos

[Science] Researchers hope some of the first rigorous placebo-controlled clinical trials of possible Long Covid treatments will report outcomes, though they may be preliminary.

[BiopharmaDive] Goldman Sachs Asset Management has wrapped up fundraising for the first fund in its Life Sciences investment venture, securing $650 million in equity commitments.